News

Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France. The agreement was announced following the successful quality audit and will...

KEY POINTS According to the WHO's top official, present conditions are suitable for COVID-19 to mutate more variants, and it is a high presumption for anyone to believe that the pandemic is reaching its end. In the third week...

The biotechnology industry in China is coming of age as a major licencing deal has been signed between RemeGen Co Ltd and Seagen Inc, a Seattle-based company. The deal marks the biggest of all between a western company and...

Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the COVID-19 omicron variant. As per the announcement made by the company, there will be a total...

Abacus Medicine Pharma Services is the new name for the healthcare and pharma services company previously known as Aposave. Simon Estcourt, Managing Director, Abacus Medicine Pharma Services explains the rebranding: “The new brand makes it very clear who we are and...

According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the coming two years. In an official announcement made by him, the single-shot vaccine against the...

As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies to take advantage of future biosimilars in the pharma landscape. This ecosystem by GlobalData positions companies on a one to five scale, predominantly on the...